Simple
Advanced Search
Field Combination
Cross Lingual Expansion
Chemical compounds (login required)

Browse by Week (PCT)
Gazette Archive
Sequence listing
National Phase Entries
National Phase Entries Full download
National Phase Entries Incremental download (last 7 days)
Authority File
Authority File Download Standard ST37
Authority File Download current year
Authority File Download All

WIPO Translate
WIPO Pearl
IPC Green Inventory
Portal to patent registers

Settings

Query
Office
Result
Download
Interface

Query Language

Stemming

Single Family Member

Include NPL

Sort by:

List Length

Result List View

Feedback

Please let us know your thoughts on PATENTSCOPE or tell us what you feel is missing or how we could improve it.

Your feedback

Contact email

Goto Application

Application Id/Number

1. WO2017007840 - OXYSTEROLS AND METHODS OF USE THEREOF

PCT Biblio. Data
Description
Claims
National Phase
Patent Family
Notices
Documents

PermaLink

Machine translation
- WIPO Translate

Publication Number WO/2017/007840

Publication Date 12.01.2017

International Application No. PCT/US2016/041175

International Filing Date 06.07.2016

IPC

A61K 31/567 2006.1

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
56	Compounds containing cyclopentahydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
565	not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol
567	substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61K 31/566 2006.1

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
56	Compounds containing cyclopentahydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
565	not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol
566	having an oxo group in position 17, e.g. oestrone

A61K 31/567 2006.1

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
56	Compounds containing cyclopentahydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
565	not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol
567	substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61K 31/566 2006.1

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
56	Compounds containing cyclopentahydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
565	not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol
566	having an oxo group in position 17, e.g. oestrone

View less classifications

CPC

A61K 31/575

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
56	Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
575	substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61K 31/58

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
56	Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
58	containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

A61P 1/00

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1	Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1	Drugs for disorders of the alimentary tract or the digestive system
04	for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

A61P 1/10

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1	Drugs for disorders of the alimentary tract or the digestive system
10	Laxatives

A61P 23/00

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
23	Anaesthetics

View more classifications

A61K 31/575

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
56	Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
575	substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61K 31/58

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
56	Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
58	containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

A61P 1/00

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1	Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1	Drugs for disorders of the alimentary tract or the digestive system
04	for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

A61P 1/10

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1	Drugs for disorders of the alimentary tract or the digestive system
10	Laxatives

A61P 23/00

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
23	Anaesthetics

A61P 25/00

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25	Drugs for disorders of the nervous system

A61P 25/04

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25	Drugs for disorders of the nervous system
04	Centrally acting analgesics, e.g. opioids

A61P 25/08

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25	Drugs for disorders of the nervous system
08	Antiepileptics; Anticonvulsants

A61P 25/14

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25	Drugs for disorders of the nervous system
14	for treating abnormal movements, e.g. chorea, dyskinesia

A61P 25/16

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25	Drugs for disorders of the nervous system
14	for treating abnormal movements, e.g. chorea, dyskinesia
16	Anti-Parkinson drugs

A61P 25/18

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25	Drugs for disorders of the nervous system
18	Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

A61P 25/20

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25	Drugs for disorders of the nervous system
20	Hypnotics; Sedatives

A61P 25/22

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25	Drugs for disorders of the nervous system
22	Anxiolytics

A61P 25/24

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25	Drugs for disorders of the nervous system
24	Antidepressants

A61P 25/28

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25	Drugs for disorders of the nervous system
28	for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

A61P 27/02

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
27	Drugs for disorders of the senses
02	Ophthalmic agents

A61P 27/16

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
27	Drugs for disorders of the senses
16	Otologicals

A61P 29/00

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29	Non-central analgesic, antipyretic or anti-inflammatory agents, e.g antirheumatic agents; Non-steroidal anti-inflammatory drugs (NSAIDs)

A61P 3/00

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3	Drugs for disorders of the metabolism

A61P 3/10

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3	Drugs for disorders of the metabolism
08	for glucose homeostasis
10	for hyperglycaemia, e.g. antidiabetics

A61P 35/00

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35	Antineoplastic agents

A61P 9/10

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9	Drugs for disorders of the cardiovascular system
10	for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

A61P 9/14

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9	Drugs for disorders of the cardiovascular system
14	Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

C07J 13/005

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
J	STEROIDS
13	Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
005	with double bond in position 16 (17)

C07J 13/007

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
J	STEROIDS
13	Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
007	with double bond in position 17 (20)

C07J 17/00

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
J	STEROIDS
17	Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton

C07J 21/00

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
J	STEROIDS
21	Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton

C07J 31/006

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
J	STEROIDS
31	Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
006	not covered by C07J31/003

C07J 41/0061

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
J	STEROIDS
41	Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
0033	not covered by C07J41/0005
0055	the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
0061	one of the carbon atoms being part of an amide group

C07J 7/002

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
J	STEROIDS
7	Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
0005	not substituted in position 21
001	substituted in position 20 by a keto group
0015	not substituted in position 17 alfa
002	not substituted in position 16

C07J 9/00

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
J	STEROIDS
9	Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

C07J 9/005

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
J	STEROIDS
9	Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
005	containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

View less classifications

Applicants

SAGE THERAPEUTICS, INC. [US]/[US]

Inventors

SALITURO, Francesco, G.
ROBICHAUD, Albert, Jean
MARTINEZ BOTELLA, Gabriel
HARRISON, Boyd, L.

Agents

YEE, Dominic, Jason

Priority Data

62/189,068		06.07.2015		US
62/332,931		06.05.2016		US

Publication Language English (en)

Filing Language English (EN)

Designated States

View all

AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)

Hide all

Title

(EN) OXYSTEROLS AND METHODS OF USE THEREOF

(FR) OXYSTÉROLS ET LEURS PROCÉDÉS D'UTILISATION

Abstract

(EN) Compounds are provided according to Formula (I) and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein R¹, R², and R³ are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.

(FR) L'invention porte sur des composés selon la formule (I) et sur des sels pharmaceutiquement acceptables de ceux-ci, ainsi que sur des compositions pharmaceutiques de ceux-ci. Dans la formule (I), R¹, R² et R³sont tels que définis dans la description. Selon la présente invention, ces composés s'avèrent utiles pour prévenir et traiter des troubles divers.

Processing

National Phase Entries

Authority File

Settings

Feedback

Goto Application

1. WO2017007840 - OXYSTEROLS AND METHODS OF USE THEREOF